Form EFFECT KIORA PHARMACEUTICALS
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 22, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity
- RIMAN Connects Global Direct Selling Leaders with K-Beauty Innovation Through WFDSA World Congress and Jeju Experience Tour
- From Vietnam National Brand to Regional Giant: SUNHOUSE Secures Second Consecutive APEA Corporate Excellence Award
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share